|
|
|
|
LEADER |
00000cam a22000007i 4500 |
001 |
SCIDIR_on1391079258 |
003 |
OCoLC |
005 |
20231120010748.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
230724s2023 ne o 000 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCO
|d UKMGB
|d OCLCF
|
015 |
|
|
|a GBC393588
|2 bnb
|
016 |
7 |
|
|a 021054904
|2 Uk
|
020 |
|
|
|a 0443188874
|q (electronic bk.)
|
020 |
|
|
|a 9780443188879
|q (electronic bk.)
|
020 |
|
|
|z 9780443188862
|
020 |
|
|
|z 0443188866
|
035 |
|
|
|a (OCoLC)1391079258
|
050 |
|
4 |
|a QP86
|
082 |
0 |
4 |
|a 612.67
|2 23/eng/20230724
|
245 |
0 |
0 |
|a Senescence, senotherapeutics and mitochondria /
|c edited by Ufuk Cakatay, Mehmet Can Atayik.
|
264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2023.
|
300 |
|
|
|a 1 online resource (264 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in protein chemistry and structural biology ;
|v volume 136
|
520 |
|
|
|a Senescence, Senotherapeutics and Mitochondria, Volume 136 offers updates on this unique topics, with chapters covering Cellular Senescence in Aging: Molecular Basis, Implications and Therapeutic Interventions, Mitochondria-associated Cellular Senescence Mechanisms: Biochemical and Pharmacological Perspectives, Mitochondria in cell senescence: Friend or Foe?, The role of mitochondria and mitophagy in cell senescence, Small molecules targeting mitochondrial dysfunction for potential senotheraputics, Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction, Mitochondrial targeting peptides and probes, Mitochondria-derived peptides in healthy ageing and therapy of age-related diseases, and much more. Other sections cover Targeting of mitostasis-proteostasis axis by antioxidant polysaccharides in neurodegeneration, Phytotherapeutic targeting of the mitochondria in neurodegenerative disorders, Melatonin as mitochondria-targeted drugs, Coenzyme Q-related compounds to maintain healthy mitochondria during aging, Changing ROS, NAD and AMP: a path to longevity via mitochondrial therapeutics, and more.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Aging
|x Molecular aspects.
|
650 |
|
0 |
|a Cells
|x Aging.
|
650 |
|
2 |
|a Cellular Senescence
|0 (DNLM)D016922
|
650 |
|
6 |
|a Vieillissement
|x Aspect mol�eculaire.
|0 (CaQQLa)201-0203052
|
650 |
|
6 |
|a Cellules
|x Vieillissement.
|0 (CaQQLa)201-0317869
|
650 |
|
7 |
|a Aging
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst00800318
|
650 |
|
7 |
|a Cells
|x Aging.
|2 fast
|0 (OCoLC)fst00850252
|
700 |
1 |
|
|a �Cakatay, Ufuk,
|e editor.
|1 https://isni.org/isni/0000000496423242
|
700 |
1 |
|
|a Atayik, Mehmet Can,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Senescence, senotherapeutics and mitochondria.
|d Amsterdam : Academic Press, 2023
|z 9780443188862
|w (OCoLC)1381951778
|
830 |
|
0 |
|a Advances in protein chemistry and structural biology ;
|v v. 136.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/18761623/136
|z Texto completo
|